Konstantinos Lontos

935 total citations · 2 hit papers
32 papers, 570 citations indexed

About

Konstantinos Lontos is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Konstantinos Lontos has authored 32 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Konstantinos Lontos's work include Acute Myeloid Leukemia Research (8 papers), CAR-T cell therapy research (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Konstantinos Lontos is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), CAR-T cell therapy research (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Konstantinos Lontos collaborates with scholars based in United States, China and Greece. Konstantinos Lontos's co-authors include Greg M. Delgoffe, B. Rhodes Ford, Amanda C. Poholek, Paolo Vignali, Nicole E. Scharping, Dayana B. Rivadeneira, McLane J. Watson, Andrew Frisch, Ashley V. Menk and Kristin DePeaux and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Konstantinos Lontos

31 papers receiving 567 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity

2022 163 citations Paolo Vignali, Kristin DePeaux et al. Nature Immunology profile →
Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism

2024 67 citations Ronal M. Peralta, Bingxian Xie et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Konstantinos Lontos United States	11	260	250	164	75	57	32	570
Won Jong Jin United States	14	215 0.8×	286 1.1×	228 1.4×	66 0.9×	32 0.6×	27	583
Samia Q. Khan United States	9	316 1.2×	193 0.8×	207 1.3×	82 1.1×	27 0.5×	11	641
Alexander Dohnal Austria	15	382 1.5×	218 0.9×	231 1.4×	69 0.9×	28 0.5×	29	648
Hannah H. Yan United States	7	377 1.4×	350 1.4×	236 1.4×	86 1.1×	42 0.7×	13	667
Myung Won Seo South Korea	10	194 0.7×	175 0.7×	201 1.2×	106 1.4×	35 0.6×	13	526
Christian Seitz Germany	11	205 0.8×	338 1.4×	246 1.5×	43 0.6×	63 1.1×	40	663
Eric H. Bent United States	6	196 0.8×	165 0.7×	252 1.5×	45 0.6×	31 0.5×	10	525
Feyza Gül Özbay Kurt Germany	10	287 1.1×	192 0.8×	159 1.0×	59 0.8×	69 1.2×	14	543
Myriam N. Bouchlaka United States	14	495 1.9×	330 1.3×	173 1.1×	38 0.5×	49 0.9×	31	822

Countries citing papers authored by Konstantinos Lontos

Since Specialization

Citations

This map shows the geographic impact of Konstantinos Lontos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantinos Lontos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantinos Lontos more than expected).

Fields of papers citing papers by Konstantinos Lontos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantinos Lontos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantinos Lontos. The network helps show where Konstantinos Lontos may publish in the future.

Co-authorship network of co-authors of Konstantinos Lontos

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantinos Lontos. A scholar is included among the top collaborators of Konstantinos Lontos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantinos Lontos. Konstantinos Lontos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lontos, Konstantinos, Rima M. Saliba, Rashmi Kanagal‐Shamanna, et al.. (2025). TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation. Blood Advances. 9(11). 2845–2854. 4 indexed citations

Frisch, Andrew, Bingxian Xie, Aaron Yang, et al.. (2025). Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy. Cell Metabolism. 37(4). 870–885.e8. 11 indexed citations

Rivadeneira, Dayana B., Kevin Quann, William Gunn, et al.. (2025). Oxidative-stress-induced telomere instability drives T cell dysfunction in cancer. Immunity. 58(10). 2524–2540.e5. 2 indexed citations

Peralta, Ronal M., Bingxian Xie, Konstantinos Lontos, et al.. (2024). Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nature Immunology. 25(12). 2297–2307. 67 indexed citations breakdown →

DePeaux, Kristin, Dayana B. Rivadeneira, Konstantinos Lontos, et al.. (2023). An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment. The Journal of Experimental Medicine. 220(10). 20 indexed citations

Lontos, Konstantinos, Yiyang Wang, Andrew Frisch, et al.. (2023). Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors. Journal for ImmunoTherapy of Cancer. 11(3). e006522–e006522. 59 indexed citations

Rivadeneira, Dayana B., William G. Gunn, Konstantinos Lontos, et al.. (2023). 386 Sheltering telomeres from oxidative damage in therapeutic T cells protects against tumor-induced immune dysfunction. SHILAP Revista de lepidopterología. A435–A435. 1 indexed citations

Vignali, Paolo, Kristin DePeaux, McLane J. Watson, et al.. (2022). Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nature Immunology. 24(2). 267–279. 163 indexed citations breakdown →

Ford, B. Rhodes, Paolo Vignali, Natalie Rittenhouse, et al.. (2022). Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells. Science Immunology. 7(74). eabj9123–eabj9123. 74 indexed citations

10.

Klem, Mary Lou, Jonathan G. Yabes, Michael Boyiadzis, et al.. (2022). Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis. The Lancet Haematology. 9(12). e906–e918. 21 indexed citations

11.

Rothenberger, Scott D., et al.. (2022). Time from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia: An analysis of 55 985 patients from the National Cancer Database. British Journal of Haematology. 199(2). 256–259. 3 indexed citations

12.

Lontos, Konstantinos, Jonathan G. Yabes, Rafic Farah, & Michael Boyiadzis. (2020). Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma. Leukemia. 35(4). 1193–1196. 4 indexed citations

13.

Adamik, Juraj, Peng Zhang, Quanhong Sun, et al.. (2019). EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets. Journal of Bone and Mineral Research. 35(1). 181–195. 33 indexed citations

14.

Zavras, Phaedon D., et al.. (2019). <p>Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date</p>. OncoTargets and Therapy. Volume 12. 4543–4554. 3 indexed citations

15.

Lontos, Konstantinos, Jonathan G. Yabes, & Michael Boyiadzis. (2019). Impact of Upfront Chemotherapy on Overall Survival in Isolated Myeloid Sarcoma. Blood. 134(Supplement_1). 2608–2608. 1 indexed citations

16.

Lontos, Konstantinos, Juraj Adamik, Anastasia Tsagianni, et al.. (2018). The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. PMC. 1 indexed citations

17.

Lontos, Konstantinos, Juraj Adamik, Anastasia Tsagianni, et al.. (2018). The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. Frontiers in Endocrinology. 9. 322–322. 41 indexed citations

18.

Nasioudis, Dimitrios, Konstantinos Lontos, Anastasia Tsagianni, Michael Boyiadzis, & Emily Ko. (2018). Acute Myeloid Leukemia Following Gynecologic Cancer in the Era of Platinum-Based Chemotherapy. International Journal of Gynecological Cancer. 28(8). 1639–1642. 1 indexed citations

19.

Lontos, Konstantinos, Mounzer Agha, Anastasios Raptis, et al.. (2017). Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation. Clinical Transplantation. 31(9). 1 indexed citations

20.

Lontos, Konstantinos, Anastasia Tsagianni, Pavlos Msaouel, Leonard J. Appleman, & Dimitrios Nasioudis. (2017). Primary Urinary Tract Lymphoma: Rare but Aggressive. Anticancer Research. 37(12). 6989–6995. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact